ALFA Filings
Every announcement, straight from the exchange
Every Kabra Drugs board meeting outcome announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Aanjaay Industries Limited announced the notice for its 37th Annual General Meeting and approved board agenda items, including the appointment of directors and auditors.
Kabra Drugs Limited approved expansion into generic branded formulations and entry into AI-driven defence manufacturing. The company will establish a dedicated AI & Defence R&D facility in Chennai and initiate SCOMET licensing. Additionally, the Board revised the postal ballot schedule, with e-voting set for May 12 to June 10, 2026.
Kabra Drugs Limited approved the appointment of Ms. Monam Kapoor as an Independent Director for five years. The Board also approved significant business diversification into drones, AI, healthcare, and dairy sectors. A postal ballot will be conducted for a company name change and MOA alteration to reflect these new business objectives.